Related Experiment Videos
[Lung transplantation in advanced pulmonary emphysema]
Therapeutische Umschau. Revue Therapeutique
|April 28, 1999
Summary
Lung transplantation has evolved into a viable treatment for end-stage pulmonary emphysema over 15 years. Advances in selection, surgical techniques, and post-operative care have significantly improved outcomes for these patients.
Area of Science:
- Pulmonary Medicine
- Surgical Innovation
- Transplantation Science
Background:
- Lung transplantation has transitioned from an experimental procedure to a standard therapy for end-stage pulmonary emphysema.
- Significant advancements have occurred over the past 15 years in managing patients with this condition.
Purpose of the Study:
- To review the progress and current status of lung transplantation for pulmonary emphysema.
- To discuss key factors contributing to improved outcomes in these patients.
Main Methods:
- Review of literature and clinical practice over the last 15 years.
- Analysis of advancements in patient selection, surgical techniques, organ preservation, and peri-operative management.
- Evaluation of optimized immunosuppressive and anti-infective strategies.
Main Results:
- Lung transplantation is now a well-established therapy for end-stage pulmonary emphysema.
- Improvements in multiple domains including patient selection, surgical procedures, post-operative care, and medical therapies have driven progress.
Conclusions:
- Lung transplantation offers a valid therapeutic option for patients suffering from end-stage pulmonary emphysema.
- Continued refinement in all aspects of the procedure and management is crucial for further success.